Special Issue "Data and Development: Drug Utilisation, Pharmacoepidemiology and Health Technology Assessment"
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (15 August 2020).
Interests: clinical pharmacy and pharmacy practice; drug utilisation review and pharmacoepidemiology; medicine use among vulnerable populations; health literacy
This Special Issue focuses on drug utilisation (“medicine use”), pharmacoepidemiology and health technology assessment to provide opportunities to assess, share and improve the use of medicines across the globe. It aims to incorporate data and development—including the UN Sustainable Development Goals (with a focus on health (SDG3 https://sustainabledevelopment.un.org/sdg3)—and will provide a scientific forum for sharing findings and initiatives which could lead to cross-national drug utilisation studies.
We invite you to contribute original research, including systematic reviews or brief reports, to this Special Issue. Topics that explore rational and quality use of medicines and improved health outcomes are welcome. Whether your research is conducted in a country where there is access to large databases of computerised records (such as claims), or whether your research has overcome challenges to provide evidence from sources such as patient charts, drug use evaluation (DUE), questionnaires, or interviews, you are invited to submit findings which contribute to the global quality use of medicines.
Assoc. Prof. Dr. Therese Kairuz
Dr. Samantha Hollingworth
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Medicine use
- Drug utilisation
- Health technology assessment
- Sustainable Development Goals